(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 8.34% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.54%.
Treace Medical Concepts's revenue in 2025 is $210,819,000.On average, 3 Wall Street analysts forecast TMCI's revenue for 2025 to be $14,277,725,670, with the lowest TMCI revenue forecast at $14,273,762,658, and the highest TMCI revenue forecast at $14,280,053,154. On average, 3 Wall Street analysts forecast TMCI's revenue for 2026 to be $15,713,405,390, with the lowest TMCI revenue forecast at $15,454,488,607, and the highest TMCI revenue forecast at $16,186,073,199.
In 2027, TMCI is forecast to generate $16,668,239,656 in revenue, with the lowest revenue forecast at $16,647,795,547 and the highest revenue forecast at $16,688,683,766.